Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
This is the ninth Covid-19 vaccine approved in India
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Entacapone tablets USP, 200 mg have an estimated market size of US$ 10.5 million for twelve months ending September 2021, according to IQVIA
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
ZY19489 is a novel anti-malarial compound active against all current clinical strains of P. falciparum and P. vivax, including drug resistant strains
Subscribe To Our Newsletter & Stay Updated
